The German pharmaceutical-and-agricultural group said the acquisition would complement its drug pipeline and leverage its ophthalmology footprint.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Date:
More like thisRelated
Dog missing for 30 days rescued from California storm drain
San Diego County animal services officers rescued a 20-pound...
Paramount Has Discussed Creating a Board to Ensure CNN’s Independence
Talks about an oversight committee began before a lawsuit...
What have 2026 NFL rookies spent their first paychecks on?
NFL NationAug 12, 2026, 06:00 AM ETCloseNFL Nation is...